Frank Rimerman Advisors
PFE icon

Frank Rimerman Advisors’s Pfizer PFE Stock Holding History

Frank Rimerman Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.69M Buy
164,556
+441
+0.3% +$11.7K 0.26% 59
2026
Q2 		$3.95M Sell
164,115
-10,769
-6% -$282K 0.22% 70
2026
Q1 		$4.91M Buy
174,884
+10,872
+7% +$289K 0.32% 51
2025
Q4 		$4.08M Sell
164,012
-32,958
-17% -$831K 0.26% 58
2025
Q3 		$5.02M Buy
196,970
+42,634
+28% +$1.05M 0.32% 47
2025
Q2 		$3.74M Buy
154,336
+13,743
+10% +$321K 0.25% 61
2025
Q1 		$3.56M Buy
140,593
+118,471
+536% +$3.1M 0.28% 58
2024
Q4 		$587K Sell
22,122
-75,752
-77% -$2.05M 0.04% 272
2024
Q3 		$2.83M Sell
97,874
-4,013
-4% -$117K 0.2% 82
2024
Q2 		$2.85M Buy
101,887
+101,573
+32,348% +$2.8M 0.2% 86
2024
Q1 		$8.71K Hold
314
– – ﹤0.01% 178
2023
Q4 		$9.04K Buy
+314
New +$9.49K ﹤0.01% 173

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
D.A. Davidson & Co
D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Frank Rimerman Advisors's PFE Position: Q3 2026 in Review

Frank Rimerman Advisors increased its Pfizer (PFE) stake by 0.27% in Q3 2026, buying an estimated $11.7K and bringing the position to 164,556 shares worth $4.69M. The position accounts for 0.26% of the portfolio, ranked #59.

Frank Rimerman Advisors first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. The position peaked at $5.02M in Q3 2025. 1,080 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Frank Rimerman Advisors held 164,556 shares of Pfizer worth $4.69M as of Q3 2026.
  • Frank Rimerman Advisors bought 441 Pfizer shares in Q3 2026, an estimated $11.7K.
  • Pfizer made up 0.26% of Frank Rimerman Advisors's portfolio in Q3 2026, its #59 holding.
  • Frank Rimerman Advisors first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
  • Frank Rimerman Advisors's Pfizer position peaked at $5.02M in Q3 2025.
  • 1,080 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Frank Rimerman Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.